Please use this identifier to cite or link to this item: http://nopr.niscpr.res.in/handle/123456789/24088
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBasu, Srabanti-
dc.contributor.authorGupta, Romita Das-
dc.contributor.authorChaudhuri, Aditi Nag-
dc.date.accessioned2013-11-22T09:13:24Z-
dc.date.available2013-11-22T09:13:24Z-
dc.date.issued2000-09-
dc.identifier.issn0975-1009 (Online); 0019-5189 (Print)-
dc.identifier.urihttp://hdl.handle.net/123456789/24088-
dc.description948-950en_US
dc.description.abstractAluminium (Al; 50 mg AlCl3/kg body wt/day) treatment caused a marked change in histological picture of normal brain as indicated by an increased number of vacuolated spaces. These changes returned to normal partially by simultaneous treatment with nifedipine (0 .7 mg/kg body wt/day) and completely by similar treatment with 50 ppm calcium (CaCl2 ; 12.5 mg/kg body wt./day). Neither nifedipine nor calcium treatment alone altered the normal histological condition. The histological changes could not be correlated with the decrease in calcineurin activities in brain as nifedipine decreases calcineurin activity without any histological changes. Hence the histological changes may be considered as specific for Al and not due to a general decrease in calcineurin activity.en_US
dc.language.isoen_USen_US
dc.publisherNISCAIR-CSIR, Indiaen_US
dc.rights CC Attribution-Noncommercial-No Derivative Works 2.5 Indiaen_US
dc.sourceIJEB Vol.38(09) [September 2000]en_US
dc.titleAluminium related changes in brain histology: Protection by calcium and nifedipineen_US
dc.typeArticleen_US
Appears in Collections:IJEB Vol.38(09) [September 2000]

Files in This Item:
File Description SizeFormat 
IJEB 38(9) 948-950.pdf751.11 kBAdobe PDFView/Open


Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.